title: Systemic administration of alkylphosphocholines. Erucylphosphocholine and liposomal hexadecylphosphocholine.
authors.affiliation: Max-Planck-Institut für biophysikalische Chemie, Am Fassberg, Göttingen, Germany.
authors.forename: P
authors.initials: P
authors.lastname: Kaufmann-Kolle
authors.forename: M R
authors.initials: MR
authors.lastname: Berger
authors.forename: C
authors.initials: C
authors.lastname: Unger
authors.forename: H
authors.initials: H
authors.lastname: Eibl
mesh_terms: D000284:Administration, Oral; D000818:Animals; D000970:Antineoplastic Agents / Q000009:adverse effects / Q000493:pharmacokinetics / Q000494:pharmacology*; D019540:Area Under Curve; D006207:Half-Life; D007275:Injections, Intravenous; D008081:Liposomes; D008325:Mammary Neoplasms, Experimental / Q000139:chemically induced / Q000188:drug therapy; D010767:Phosphorylcholine / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000493:pharmacokinetics / Q000494:pharmacology; D051381:Rats; D017207:Rats, Sprague-Dawley; D017208:Rats, Wistar; D014407:Tumor Cells, Cultured
chemical_list: D000970:Antineoplastic Agents; D008081:Liposomes; D010767:Phosphorylcholine; C075010:erucylphosphocholine; C039128:miltefosine